May 12, 2026

Mental health month 2026: how mobile EEG and VR are making professional mental support accessible to everyone

Senior Technical Delivery Manager in Healthcare and MedTech

A relaxed woman wearing VR glasses

FOR PRESS USE: Feel free to use excerpts, statistics, or quotes from this material for your reporting. 

Every May, during Mental Health Awareness Month, conversations about mental health become a little louder. But behind the campaigns and social posts, there is a quieter reality that rarely changes: many people still cannot get the help they need.

The numbers prove it and the scale of the problem is hard to ignore. According to a September 2025 report from the World Health Organization, more than one billion people are living with a mental health condition. Over the course of a lifetime, about half of all people will face some form of mental health disorder.

What is more concerning is the gap between need and care. Only 9% of people with depression receive treatment that meets even basic standards. So it stands to reason that this is not just a healthcare issue. It is a global access problem that continues to leave millions without support.

Burnout makes the situation even harder to ignore. In 2025, two thirds of employees in the United States say they feel burned out in some way, according to the new research from Moodle (conducted by the research consultants at Censuswide). Concerns about AI and job security, constant pressure at work, and the aftereffects of recent global disruptions have created a workforce that is quietly struggling, often without real support.

At the same time, access to care is shrinking. The United States is expected to see a 20% drop in practicing psychiatrists by 2030. Public investment tells a similar story. Governments spend about 2% of their health budgets on mental health. In many lower income countries, that number falls below 1%.

The math does not work. There are not enough therapists for everyone. There is not enough money. There is not enough time.

At Innowise, we ask a different question: not how do we replace the therapist, but how do we make meaningful support available in the moments when a therapist is not there? The answer, increasingly, lies in Digital Therapeutics (DTx) — and the results are changing what professional-grade mental healthcare can mean.

Digital therapeutics — software as a healing tool

Digital Therapeutics refers to software-based interventions (delivered through smartphones, tablets, wearables, or immersive devices) that have been clinically validated to prevent, manage, or treat medical conditions, including mental health disorders. You shouldn’t treat DTx as just wellness content or motivational apps. This is evidence-based treatment, delivered through code.

The industry has matured rapidly. The global DTx market was valued at $10.15 billion in 2025 and is projected to reach $67.58 billion by 2034, growing at a compound annual rate of 23.5%, according to Fortune Business Insights.

Regulatory bodies are catching up. In January 2025, the U.S. Centers for Medicare & Medicaid Services (CMS) began reimbursing certain FDA-authorized digital mental health treatments under Medicare. This is definitely a watershed moment that signals regulators now treat clinically validated software as medicine, not as a consumer product. On top of that, the world’s top pharmaceutical companies have already partnered with DTx developers to build digital interventions alongside traditional drug therapies.

Two technologies sit at the heart of the most promising DTx applications for mental health: biofeedback and real-time AI analytics.

Biofeedback uses physiological sensors to measure brain activity, heart rate variability, skin conductance, and respiration. This way, it gives users objective, real-time data about what their body and nervous system are doing. Where traditional therapy relies on self-report (“I feel anxious”), biofeedback makes the invisible visible. 

AI analytics then processes this data continuously, detecting patterns, personalizing interventions, and adapting therapeutic protocols to the individual in ways no human clinician could do at scale.

Together, these tools shift mental health support from an episodic, appointment-dependent model to a continuous, responsive one. They reach people in real life moments. Late at night. In a hotel room. During a spike of stress. Support is there when it is needed, not only at a fixed time or place.

From clinical theory to a working device — the smart meditation case

Understanding what this looks like in practice requires moving from abstraction to application.

Smart Meditation, a project developed with Innowise’s engineering expertise, represents exactly this translation. The system pairs a consumer VR headset with a portable EEG sensor, which is a brain activity tracker worn comfortably on the head, to create a biofeedback-driven meditation environment. The user enters an immersive virtual setting: a calm landscape, a quiet forest, an abstract space designed to reduce cognitive load. The EEG sensor monitors their brainwave activity in real time.

What makes this more than a relaxation app is the feedback loop. The user does not simply watch a calming scene and hope for the best. They can observe, directly and objectively, how their own brain responds, watching their relaxation deepen, their stress signals diminish, their focus consolidate. The virtual environment itself adapts to their neurological state, guided by AI that has been trained on clinical data. The result is a session that is simultaneously immersive and measurable, subjective and scientific.

This is what serious digital therapeutics development looks like: peer-reviewed methodology, measurable outcomes, and institutional validation. Smart Meditation’s clinical credibility is further supported by backing from the European Bank for Reconstruction and Development (EBRD).

The digital bridge: an expert perspective

Mental health technology often raises a fair question. Are these tools helping people access care, or are they replacing the human connection that care depends on?

And the honest answer is that the concern applies to bad technology. These are apps that substitute engagement metrics for outcomes, collect vulnerable people’s data for advertising, and reduce complex human suffering to a productivity optimization problem.

The way Innowise approaches this is simpler than it may sound. Technology is not there to replace care. It is there to fill the gap when care is not immediately available.

Think about the moments between sessions. When stress builds late at night. When something triggers anxiety and there is no one to talk to right away. This is where digital tools can help a lot. Not as a substitute for a therapist, but as support that helps people stay grounded and aware of what is happening to them.

Something interesting happens when people can actually see how their body responds. For example, during a VR session with biofeedback, a person can watch their brain activity or heart rate change in real time. What used to be a vague feeling becomes something clear and visible. It is no longer just “I feel calmer.” It becomes “I can see that I am calmer.”

That shift matters. People stop feeling like passive patients who wait for help. They start understanding their own patterns and reactions. They gain a sense of control, even in difficult moments.

Technology, in this sense, does not take the place of a clinician. It extends their presence. It gives people a way to stay connected to their own mental state every day, not just during appointments.

Ethics and data security in mental health DTx — trust as a technical requirement

Mental Health Awareness Month is, among other things, a reminder of how much courage it takes to seek help. People who engage with mental health technology are sharing some of the most sensitive information that exists: their psychological states, their fears, their lowest moments.

That trust must be earned — technically, legally, and ethically — before a single line of therapeutic code is written.

In 2026, the regulatory environment has sharpened considerably. The 2026 HIPAA Security Rule update introduces mandatory encryption, multi-factor authentication, and rigorous documentation requirements for any app handling protected health information. GDPR, for users in the European Union, requires explicit, granular consent for processing mood logs, therapy session records, and other sensitive mental health data. Developers building for international markets must treat these frameworks as complementary architecture, not conflicting compliance burdens.

At Innowise, compliance is not a post-development checklist. It is a design constraint from day one. This is what practitioners now call “privacy by design.” This means encrypted data pipelines, role-based access controls, and AI models trained on anonymized or synthetic datasets wherever clinically appropriate. It means transparent consent flows that explain, in plain language, what data is collected and why.

It also means building AI systems that include human oversight mechanisms. This is a requirement that regulators and clinical ethicists increasingly treat as non-negotiable for any AI operating in contexts involving vulnerable populations.

Making professional support accessible to millions

Mental Health Awareness Month exists because awareness is not yet universal, and because awareness alone is not enough. The distance between knowing one needs help and actually receiving it remains, for hundreds of millions of people, an uncrossable gap. Mostly, it’s defined by geography, cost, stigma, and simple scarcity of trained professionals.

Digital Therapeutics does not close that gap through substitution. It closes it through extension, reaching into the hours between sessions, the towns without psychiatrists, the moments of crisis that don’t wait for Monday morning.

The combination of mobile EEG, immersive VR, and real-time AI analytics represents a genuinely new category of care: objective, personalized, continuous, and accessible to anyone with a smartphone or a VR headset. As Medicare reimbursement policies continue to evolve, as more clinical evidence becomes available, and as development teams treat trust as a core requirement, access to these solutions will keep growing.

FOR PRESS USE: Feel free to use excerpts, statistics, or quotes from this material for your reporting.

    Contact our press office

    Please be informed that when you click the send button Innowise will process your personal data in accordance with our Privacy Policy for the purpose of providing you with appropriate information.

    manager photo
    Lizaveta Piaskova PR & Communications Manager

    Thank you!

    Your message has been sent.
    We’ll process your request and contact you back as soon as possible.

    arrow